SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
VICL (Vical Labs)
An SI Board Since March 1996
Posts SubjectMarks Bans Symbol
1972 55 0 VICL
Emcee:  bob clark Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1622Vical Announces Patents on Gene Delivery Technologies Thursday January 8, 4:30 pbob zagorin-1/8/2004
1621Ebola Vaccine Shows Promise in Mice Mon December 08, 2003 05:36 PM ET NEW YORKbob zagorin-12/9/2003
1620U.S. starts trial of Ebola vaccine WASHINGTON, Nov 18 (Reuters) - U.S. researchbob zagorin-11/18/2003
1619Vical And NIH Developing Ebola Vaccine Tuesday November 18, 1:22 pm ET SAN DIEbob zagorin-11/18/2003
1618>>SAN DIEGO, Nov. 18 /PRNewswire-FirstCall/ -- Vical Incorporated (Nasdaq:tuck-11/18/2003
1617US scientists warn CIA of new generation of bioweapons Mon Nov 17, 9:37 AM ET bob zagorin-11/17/2003
1616ERN/CALL: VICL To Hold Q3 Conf Call @ 12:00 ET Today [delayed] 11/05/2003 09bob zagorin-11/6/2003
1615Vical Announces Third-Quarter 2003 Financial Results Wednesday November 5, 8:30 bob zagorin-11/5/2003
1614US develops lethal new viruses 19:00 29 October 03 A scientist funded by thebob zagorin-10/31/2003
1613Vical Announces News Release and Conference Call Schedule For Third Quarter 2003bob zagorin-10/29/2003
1612Vical Inc. (VICL) Licenses Core Technology To Aqua Health Ltd. SAN DIEGO, Oct.bob zagorin-10/28/2003
1611Researchers Find Possible New Antibiotic Thu October 23, 2003 03:56 PM ET WASHbob zagorin-10/24/2003
1610Smallpox Still an Ideal Bioterror Agent, Experts Say Mon October 20, 2003 12:51 bob zagorin-10/21/2003
1609Genetronics Announces Option for a License Agreement With Vical Monday October 2bob zagorin-10/20/2003
1608Vical and NIH to Develop West Nile Virus Vaccine Monday October 20, 8:30 am ET bob zagorin-10/20/2003
1607Vical Begins Manufacturing SARS Vaccine for VRC SAN DIEGO, Oct. 13 /PRNewswire-nigel bates-10/13/2003
1606Vical Announces Webcast of CEO Presentation at UBS Global Life Sciences Conferenbob zagorin-9/17/2003
1605Research on Dengue Vaccine Gets A $55 Million Foundation Grant By MARILYN CHASEbob zagorin-9/10/2003
1604Vical Announces Webcast of CEO Presentation at BioCentury Newsmakers Conference bob zagorin-8/29/2003
1603That news seems spun. It's nice to know Merck is interested in working on tA.J. Mullen-8/21/2003
1602Vical Grants Options to Merck for Cancer Targets SAN DIEGO, Aug 21, 2003 /PRNbob zagorin-8/21/2003
1601Source: NIH/National Institute Of Allergy And Infectious Diseases Date: 20bob zagorin-8/19/2003
1600Vical Files $50 Million Shelf Registration SAN DIEGO, Aug. 14 /PRNewswire-Firstbob zagorin-8/14/2003
1599from the 10q filed today "...We anticipate that our available cash and exibob zagorin-8/13/2003
1598From Dr. Nabel's interview this afternoon: Dr. Gary Nabel: We regard the scTiger-8/7/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News